Phosphorylation of Alzheimer β-Amyloid Precursor-like Proteins

Toshiharu Suzuki,* Kanae Ando, Toshio Isohara,§ Masaki Oishi, Gloria S. Lim, Yasushi Satoh, Wilma Wasco, Rudolph E. Tanzi, Angus C. Nairn, Paul Greengard, Samuel E. Gandy, and Yutaka Kirino
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113, Japan, Life Science Research Center, Advanced Technology Research Laboratories, Nippon Steel Corporation, Ida 3-55-1, Nakamura-ku, Kawasaki 211, Japan, Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York 10021, Laboratory of Genetics and Aging, Neuroscience Center, Massachusetts General Hospital, Charlestown, Massachusetts 02129, and Department of Neurology and Neuroscience, The New York Hospital Cornell Medical Center, New York, New York 10021
Biochemistry, 1997, 36 (15), pp 4643–4649
DOI: 10.1021/bi962618k
Publication Date (Web): April 15, 1997
Copyright © 1997 American Chemical Society

 This research was supported by Terumo Life Science Foundation (T.S.), by a Grant-in-Aid for Scientific Research from The Japanese Ministry of Education, Science and Culture [nos. 07457536 (T.S.), 07557143 (Y.K.), and 08457591 (Y.K.)] and a grant from the Program for Promotion of Basic Research Activity for Innovative Bioscience, and by U.S. PHS grants AG11508 (S.G.), AG09464 (S.G., A.N., P.G.), and AG10491 (S.G, P.G.).

,
*

 Address correspondence to this author at Laboratory of Neurobiophysics, Faculty of Pharmaceutical Sciences, The University of Tokyo. Tel/Fax:  81-3-3814-6937. E-mail: t-suzuki@mayqueen.f.u-tokyo.ac.jp.

,

 The University of Tokyo.

,
§

 Nippon Steel Corporation.

,

 The Rockefeller University.

,

 Massachusetts General Hospital.

,

 The New York Hospital-Cornell Medical Center.

Abstract

Amyloid precursor-like proteins (APLPs), APLP1 and APLP2, are members of a gene family which include the Alzheimer β-amyloid precursor protein (APP). APLP1, APLP2, and APP contain highly homologous amino acid sequences, especially in their cytoplasmic domains, although APLPs lack the β-amyloid domain derived by proteolytic processing from APP. APP is phosphorylated at three sites in the cytoplasmic domain in cultured cells and adult rat brain [Suzuki et al. (1994) EMBO J. 13, 1114−1122; Oishi, et al. (1997) Mol. Med. 3, 109−121] and at sites in the extracellular domain in cultured cells [Knops et al. (1993) Biochem. Biophys. Res. Commun. 197, 380−385; Hung & Selkoe (1994) EMBO J. 13, 534−542; Walter et al. (1997) J. Biol. Chem. 272, 1896−1903]. We report here that a cytoplasmic domain peptide from APLP1 is phosphorylated in vitro by protein kinase C and that a cytoplasmic domain peptide from APLP2 is phosphorylated in vitro by protein kinase C and cdc2 kinase. APLP2 is phosphorylated by cdc2 kinase at a site homologous to the cdc2 kinase site phosphorylated in APP. Furthermore, phosphorylation of this site occurs in a cell cycle-dependent manner in cultured cells. These findings indicate that in intact cells the phosphorylation of APLP2 appears to be regulated in a similar fashion to that of APP.

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

History

  • Published In Issue April 15, 1997
  • Received October 18, 1996
    Revised Manuscript Received February 10, 1997

Recommend & Share